Phase Forward (PFWD) will be acquired by Oracle (ORCL) for $17/share, or about $685M. Phase...

|About: Oracle Corporation (ORCL)|By:, SA News Editor

Phase Forward (PFWD) will be acquired by Oracle (ORCL) for $17/share, or about $685M. Phase Forward's software helps accelerate innovation in drug development and patient care delivery, and will compliment Oracle's Health Sciences unit. PFWD +29% premarket to $16.87. ORCL -0.4%.